Heart failure & cardiomyopathies

Value of plasma D-dimer level for prediction of in-hospital mortality in patients presenting with Takotsubo syndrome

Eur Heart J Acute Cardiovasc CarePublished retrospective analysis of registry data

Main finding · In-hospital all-cause deathResult — go to the resultOdds ratio 7.06 95% CI 2.90–17.16

Authors' conclusion

Elevated D-dimer levels may serve as an additional predictor of increased in-hospital mortality in patients with TTS. Patients with higher D-dimer levels may warrant intensified monitoring and management.

Study context

Population
Patients with Takotsubo syndrome (TTS)patients with TTS
Participants
580 patients
Exposure
D-dimer level and in-hospital mortality; additive effect of D-dimer level on the InterTAK prognostic risk score
Outcome
In-hospital all-cause death
Follow-up
In-hospital
Methodological detailsTokyo Cardiovascular Care Unit Network registry
  • Tokyo Cardiovascular Care Unit Network registry

Main finding

As reported in the abstract

Odds ratio

7.06

95% CI 2.90–17.16

P < 0.001

D-dimer levels ≥3.5 µg/mL
OR 7.06 (95% CI 2.90–17.16); P < 0.001
Deaths
28 (4.8%)
Cardiac death
n = 13, 46.4%
Non-cardiac death
n = 15, 53.6%

Observational data: associations, not effects.

Further findings

D-dimer levels on admission · significantly higher in those who died

P < 0.001

Baseline characteristics

Median age
77 years
Women
79.5%
Emotional trigger
174 (30.0%)
Physical trigger
177 (30.5%)

Incremental value of D-dimer added to InterTAK Prognostic Score

InterTAK Prognostic Score
17 (11-24)
Net reclassification improvement (NRI)
1.08, P < 0.001
Integrated discrimination improvement (IDI)
0.05, P < 0.001

Original publication

Value of plasma D-dimer level for prediction of in-hospital mortality in patients presenting with Takotsubo syndrome. Eur Heart J Acute Cardiovasc Care. Published 17 December 2025. doi:10.1093/ehjacc/zuaf166

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.